Gabapentin Enacarbil Market 2027 By Type, Application and Geography | The Insight Partners

Gabapentin Enacarbil Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Capsule, Tablet); Application (Post-Herpetic Neuralgia (PHN), Restless Legs Syndrome (RLS), Others) and Geography

Report Code: TIPRE00018109 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Gabapentin enacarbil is an analgesic and anticonvulsant drug of the gabapentinoid class and a prodrug to gabapentin. This medication is used to treat moderate to severe restless legs syndrome. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection).

MARKET DYNAMICS

Factors contributing to the Gabapentin enacarbil market's growth include the high prevalence of neurological disorders among the population and increasing R & D in analgesic drugs. However, the side effects of the drug-like dizziness, drowsiness, and ataxia, can restrain the market growth.

MARKET SCOPE

The "Gabapentin Enacarbil Market Analysis to 2027" is a specialized and in-depth study of the Pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of gabapentin enacarbil market with detailed market segmentation with type and application. The gabapentin enacarbil market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in gabapentin enacarbil market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The gabapentin enacarbil market is segmented on the basis of type and application. On the basis of type, the gabapentin enacarbil market is divided as capsule and tablet. Based on application, the gabapentin enacarbil market can be segmented into post-herpetic neuralgia (phn), restless legs syndrome (rls) and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the gabapentin enacarbil market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The gabapentin enacarbil market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyses factors affecting gabapentin enacarbil market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the gabapentin enacarbil market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in gabapentin enacarbil market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from gabapentin enacarbil market are anticipated to have lucrative growth opportunities in the future with the rising demand for gabapentin enacarbil in the global market. Below mentioned is the list of few companies engaged in the gabapentin enacarbil market.

The report also includes the profiles of key players in gabapentin enacarbil market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •  GlaxoSmithKline plc
  •  Sun Pharmaceutical Industries Ltd.
  •  Novartis AG
  •  Pfizer Inc.
  •  Glenmark Pharmaceuticals Limited
  •  Astellas Pharma Inc.
  •  AstraZeneca plc
  •  Aurobindo Pharma.
  •  Takeda Pharmaceutical Company Limited
  •  Intas Pharmaceuticals Ltd.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Gabapentin Enacarbil Market - By Type
1.3.2 Gabapentin Enacarbil Market - By Application
1.3.3 Gabapentin Enacarbil Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. GABAPENTIN ENACARBIL MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. GABAPENTIN ENACARBIL MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. GABAPENTIN ENACARBIL MARKET - GLOBAL MARKET ANALYSIS
6.1. GABAPENTIN ENACARBIL - GLOBAL MARKET OVERVIEW
6.2. GABAPENTIN ENACARBIL - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. GABAPENTIN ENACARBIL MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. CAPSULE
7.3.1. Overview
7.3.2. Capsule Market Forecast and Analysis
7.4. TABLET
7.4.1. Overview
7.4.2. Tablet Market Forecast and Analysis
8. GABAPENTIN ENACARBIL MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. POST-HERPETIC NEURALGIA (PHN)
8.3.1. Overview
8.3.2. Post-Herpetic Neuralgia (PHN) Market Forecast and Analysis
8.4. RESTLESS LEGS SYNDROME (RLS)
8.4.1. Overview
8.4.2. Restless Legs Syndrome (RLS) Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis

9. GABAPENTIN ENACARBIL MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Gabapentin Enacarbil Market Overview
9.1.2 North America Gabapentin Enacarbil Market Forecasts and Analysis
9.1.3 North America Gabapentin Enacarbil Market Forecasts and Analysis - By Type
9.1.4 North America Gabapentin Enacarbil Market Forecasts and Analysis - By Application
9.1.5 North America Gabapentin Enacarbil Market Forecasts and Analysis - By Countries
9.1.5.1 United States Gabapentin Enacarbil Market
9.1.5.1.1 United States Gabapentin Enacarbil Market by Type
9.1.5.1.2 United States Gabapentin Enacarbil Market by Application
9.1.5.2 Canada Gabapentin Enacarbil Market
9.1.5.2.1 Canada Gabapentin Enacarbil Market by Type
9.1.5.2.2 Canada Gabapentin Enacarbil Market by Application
9.1.5.3 Mexico Gabapentin Enacarbil Market
9.1.5.3.1 Mexico Gabapentin Enacarbil Market by Type
9.1.5.3.2 Mexico Gabapentin Enacarbil Market by Application
9.2. EUROPE
9.2.1 Europe Gabapentin Enacarbil Market Overview
9.2.2 Europe Gabapentin Enacarbil Market Forecasts and Analysis
9.2.3 Europe Gabapentin Enacarbil Market Forecasts and Analysis - By Type
9.2.4 Europe Gabapentin Enacarbil Market Forecasts and Analysis - By Application
9.2.5 Europe Gabapentin Enacarbil Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Gabapentin Enacarbil Market
9.2.5.1.1 Germany Gabapentin Enacarbil Market by Type
9.2.5.1.2 Germany Gabapentin Enacarbil Market by Application
9.2.5.2 France Gabapentin Enacarbil Market
9.2.5.2.1 France Gabapentin Enacarbil Market by Type
9.2.5.2.2 France Gabapentin Enacarbil Market by Application
9.2.5.3 Italy Gabapentin Enacarbil Market
9.2.5.3.1 Italy Gabapentin Enacarbil Market by Type
9.2.5.3.2 Italy Gabapentin Enacarbil Market by Application
9.2.5.4 Spain Gabapentin Enacarbil Market
9.2.5.4.1 Spain Gabapentin Enacarbil Market by Type
9.2.5.4.2 Spain Gabapentin Enacarbil Market by Application
9.2.5.5 United Kingdom Gabapentin Enacarbil Market
9.2.5.5.1 United Kingdom Gabapentin Enacarbil Market by Type
9.2.5.5.2 United Kingdom Gabapentin Enacarbil Market by Application
9.2.5.6 Rest of Europe Gabapentin Enacarbil Market
9.2.5.6.1 Rest of Europe Gabapentin Enacarbil Market by Type
9.2.5.6.2 Rest of Europe Gabapentin Enacarbil Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Gabapentin Enacarbil Market Overview
9.3.2 Asia-Pacific Gabapentin Enacarbil Market Forecasts and Analysis
9.3.3 Asia-Pacific Gabapentin Enacarbil Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Gabapentin Enacarbil Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Gabapentin Enacarbil Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Gabapentin Enacarbil Market
9.3.5.1.1 Australia Gabapentin Enacarbil Market by Type
9.3.5.1.2 Australia Gabapentin Enacarbil Market by Application
9.3.5.2 China Gabapentin Enacarbil Market
9.3.5.2.1 China Gabapentin Enacarbil Market by Type
9.3.5.2.2 China Gabapentin Enacarbil Market by Application
9.3.5.3 India Gabapentin Enacarbil Market
9.3.5.3.1 India Gabapentin Enacarbil Market by Type
9.3.5.3.2 India Gabapentin Enacarbil Market by Application
9.3.5.4 Japan Gabapentin Enacarbil Market
9.3.5.4.1 Japan Gabapentin Enacarbil Market by Type
9.3.5.4.2 Japan Gabapentin Enacarbil Market by Application
9.3.5.5 South Korea Gabapentin Enacarbil Market
9.3.5.5.1 South Korea Gabapentin Enacarbil Market by Type
9.3.5.5.2 South Korea Gabapentin Enacarbil Market by Application
9.3.5.6 Rest of Asia-Pacific Gabapentin Enacarbil Market
9.3.5.6.1 Rest of Asia-Pacific Gabapentin Enacarbil Market by Type
9.3.5.6.2 Rest of Asia-Pacific Gabapentin Enacarbil Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Gabapentin Enacarbil Market Overview
9.4.2 Middle East and Africa Gabapentin Enacarbil Market Forecasts and Analysis
9.4.3 Middle East and Africa Gabapentin Enacarbil Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Gabapentin Enacarbil Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Gabapentin Enacarbil Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Gabapentin Enacarbil Market
9.4.5.1.1 South Africa Gabapentin Enacarbil Market by Type
9.4.5.1.2 South Africa Gabapentin Enacarbil Market by Application
9.4.5.2 Saudi Arabia Gabapentin Enacarbil Market
9.4.5.2.1 Saudi Arabia Gabapentin Enacarbil Market by Type
9.4.5.2.2 Saudi Arabia Gabapentin Enacarbil Market by Application
9.4.5.3 U.A.E Gabapentin Enacarbil Market
9.4.5.3.1 U.A.E Gabapentin Enacarbil Market by Type
9.4.5.3.2 U.A.E Gabapentin Enacarbil Market by Application
9.4.5.4 Rest of Middle East and Africa Gabapentin Enacarbil Market
9.4.5.4.1 Rest of Middle East and Africa Gabapentin Enacarbil Market by Type
9.4.5.4.2 Rest of Middle East and Africa Gabapentin Enacarbil Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Gabapentin Enacarbil Market Overview
9.5.2 South and Central America Gabapentin Enacarbil Market Forecasts and Analysis
9.5.3 South and Central America Gabapentin Enacarbil Market Forecasts and Analysis - By Type
9.5.4 South and Central America Gabapentin Enacarbil Market Forecasts and Analysis - By Application
9.5.5 South and Central America Gabapentin Enacarbil Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Gabapentin Enacarbil Market
9.5.5.1.1 Brazil Gabapentin Enacarbil Market by Type
9.5.5.1.2 Brazil Gabapentin Enacarbil Market by Application
9.5.5.2 Argentina Gabapentin Enacarbil Market
9.5.5.2.1 Argentina Gabapentin Enacarbil Market by Type
9.5.5.2.2 Argentina Gabapentin Enacarbil Market by Application
9.5.5.3 Rest of South and Central America Gabapentin Enacarbil Market
9.5.5.3.1 Rest of South and Central America Gabapentin Enacarbil Market by Type
9.5.5.3.2 Rest of South and Central America Gabapentin Enacarbil Market by Application

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. GABAPENTIN ENACARBIL MARKET, KEY COMPANY PROFILES
11.1. GLAXOSMITHKLINE PLC
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. SUN PHARMACEUTICAL INDUSTRIES LTD.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. NOVARTIS AG
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. PFIZER INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. GLENMARK PHARMACEUTICALS LIMITED
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ASTELLAS PHARMA INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. ASTRAZENECA PLC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. AUROBINDO PHARMA.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. TAKEDA PHARMACEUTICAL COMPANY LIMITED
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. INTAS PHARMACEUTICALS LTD.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. GlaxoSmithKline plc
2. Sun Pharmaceutical Industries Ltd.
3. Novartis AG
4. Pfizer Inc.
5. Glenmark Pharmaceuticals Limited
6. Astellas Pharma Inc.
7. AstraZeneca plc
8. Aurobindo Pharma.
9. Takeda Pharmaceutical Company Limited
10. Intas Pharmaceuticals Ltd.
TIPRE00018109
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking